Frontlight ResearchEarly access
Trial site
Necmettin Erbakan University Meram Medical Faculty
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Psoriasis2 trials
- Stroke2 trials
- Bladder cancer1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Psoriatic arthritis1 trial
- and 2 more
- Phase
- Phase 38 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Amgen1 trial
- argenx1 trial
- BioNTech SE1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026